金素依赖性:当前的观点和未来研究问题的问题
Curtis R Coughlin1, Sidney M Gospe2,3
1Section of Clinical Genetics and Metabolism, Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
概括
甲素依赖性 (PDE) 是一种影响素代谢的遗传疾病. 基因测试和生物标志物的进步为PDE-ALDH7A1.1.提供了更好的诊断和治疗方法.
科学领域:
- 生物化学 生物化学
- 遗传学 遗传学 是一个
- 神经学 神经学
背景情况:
- 历史上通过pyridoxine试验诊断的pyridoxine依赖性 (PDE).
- 研究显示PDE源于遗传疾病,最常见的是PDE-ALDH7A1.1.
- PDE-ALDH7A1涉及 lysine代谢中的酶缺乏.
研究的目的:
- 审查了解和诊断PDE-ALDH7A1.1.的进展.
- 为了突出PDE-ALDH7A1在之外的更广泛的临床谱.
- 讨论未来管理这种复杂疾病的方向.
主要方法:
- 七十年来研究的文献综述.
- 对PDE-ALDH7A1患者的临床和生化发现的分析.
- 讨论包括生物标志物和遗传检测在内的诊断进步.
主要成果:
- PDE-ALDH7A1呈现,大脑发育异常和智力障碍.
- 解决代谢缺陷的有针对性的治疗改善了结果.
- 新的生物标志物和基因测试使得在不需要皮里多克素试验的情况下进行诊断.
结论:
- PDE-ALDH7A1是一种复杂的疾病,目前仍面临着研究挑战.
- 诊断工具正在得到改进,为新生儿查铺平了道路.
- 国际合作和模型系统为未来的进步提供了乐观的预期.
关键词:
在ALDH7A1中,PLPBP PLPBP 这是一个很大的问题.在 PNPOPO 里面.抗素是一种抗素.lysine-restriction-restriction lysine-restriction lysine-restriction lysine-restriction lysine-restriction lysine-restriction lysine-restriction lysine-restriction lysine-restriction lysine-restriction lysine-restriction lysine-restriction lysine-restriction lysine-restriction lysine-restriction lysine-restriction lysine-restriction lysine-restriction lysine-restriction lysine-restriction lysine-restriction lysine-restriction lysine-restriction lysine-restriction lysine-restriction lysine-restriction lysine-restriction lysine-restriction lysine-restriction lysine-restriction lysine-restriction lysine-restriction lysine-restriction lysine-restriction lysine-restriction新生儿发作 新生儿发作新生儿查 新生儿查维生素B6 维生素B6 是一种维生素.相关概念视频
Epilepsy and Seizures: Overview
274
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
274
Antiepileptic Drugs: GABAergic Pathway Potentiators
632
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
632
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
439
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
439
Antiepileptic Drugs: Glutamate Antagonists
509
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
509
Seizures: Classification
582
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
582
Antiepileptic Drugs: Potassium Channel Activators
272
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
272


